Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01028300 · ClinicalTrials.gov registry record · NA

Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel

A NA study, sponsored by Synthes USA HQ.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT01028300: Clinical Trial NA study, sponsored by Synthes USA HQ.

NCT01028300 is a NA study that was terminated before completion, run by Synthes USA HQ. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01028300, a NA study, was terminated before completion, sponsored by Synthes USA HQ.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

Degenerative disc disease (DDD) refers to a syndrome in which a degenerating disc causes chronic back pain, significantly impacting an individual's ability to function. The condition is most commonly diagnosed in the lumbosacral spinal segments L3-S1. The condition often starts with an injury to the disc space. The injury weakens the disc and creates excessive motion at the corresponding vertebral level. Over time, the segmental instability and associated neurological compromise combined with ongoing inflammatory processes that occur in and around the disc produce low back pain. The reparative processes in the disc are poor, thus the painful symptoms can become chronic. Premature degeneration at adjacent levels of the spine remains one of the more vexing problems facing spinal surgeons when advising relatively young people to consider lumbar fusion surgery. Stopping the motion changes the mechanics of the back (which is designed for motion and flexibility) and results in the transfer of the loads and stresses to the adjacent vertebral segments. It is therefore intuitive to pursue total disc replacement, which allows for the treatment of pain due to DDD while re-establishing motion and stability, load distribution, and restoring the disc height, as an alternative to spinal fusion surgery. The study hypothesis is that military personnel receiving Total Disc Replacement will return to the same level of active duty performance as at the time of their most recent successful physical readiness test.

Interventions

  • DEVICE ProDisc™-L Total Disc Replacement (TDR)

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2010-04
Est. Completion 2011-03
Phase NA
Synthes USA HQ

7 total trials

Why NCT01028300 stopped before completion

NCT01028300 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which ProDisc™-L Total Disc Replacement (TDR) is the first listed.

NCT01028300 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01028300 about?

NCT01028300 is a clinical study titled "Clinical Outcomes of Lumbar Degenerative Disc Disease in Active-Duty U.S. Service Personnel". Degenerative disc disease (DDD) refers to a syndrome in which a degenerating disc causes chronic back pain, significantly impacting an individual's ability to function. The condition is most commonly diagnosed in the lumbosacral spinal segments L3-S1. The condition often starts with an injury to the...

What is the current status of trial NCT01028300?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2010-04. Estimated completion is 2011-03.

What interventions are being tested in trial NCT01028300?

The interventions under investigation include: ProDisc™-L Total Disc Replacement (TDR) (DEVICE).

Who is sponsoring clinical trial NCT01028300?

This trial is sponsored by Synthes USA HQ, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01028300's enrollment target sits among peer trials

4 1996th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01028300, the US trial registry maintained by the National Library of Medicine. NCT01028300 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.